Skip to main content
Caplight Logo









Epitel, Inc.

Epitel, Inc.

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://www.epitel.com/

Last Round

Series B

Jul 28, 2026

Est. Valuation

$88M

Total Funding Raised

$53.6M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Epitel, Inc. is a digital health company that develops and commercializes wearable, wireless electroencephalogram (EEG) monitoring technology for seizure detection.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Healthcare Analytics, Sensors

Business Model

B2B

Customer Profile

Usage-Based SaaS, Hardware Sales

AI Layer

Application

Keywords

electroencephalogramEEGseizure monitoringwearable EEGremote patient monitoringRPMseizure detectionmedical deviceclinical decision supportdigital healthneurology softwarepoint of care testingPOCThealth IoTwearable sensors

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epitel, Inc. Comparables

Compare Epitel, Inc. with similar companies based on industry and business-model similarity.

Epitel, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Zeto, Inc.
91%
Ceribell
80%
NeuroServo
79%

Epitel, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJul 28, 2026
Series AFeb 16, 2022
GrantFeb 15, 2022
SeedDec 16, 2019
GrantJan 25, 2017

Key People

Founding team and executive leadership

Steve Pacelli

Chief Executive Officer

Executive Team

Steven Pacelli

Chief Executive Officer

Executive Team

Mark Lehmkuhle

CTO

Executive Team

Epitel, Inc. Investors

Notable investors and investment history

Epitel, Inc. investors
InvestorRounds
IdeashipSeed
NIH RADxGrant
OSF VenturesSeries A
Dexcom VenturesSeries A
Genoa VenturesSeries B, Series A
Wavemaker Three-Sixty HealthSeries A
Epilepsy FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    $26M round led by Catalyst Health Ventures and Genoa Ventures.

  • Jun 18, 2026

    Monthly visitors increased 45% MoM.

Epitel, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epitel, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epitel, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range59
Year Founded2007
Last FundingJul 28, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?